Google has announced a new advertising policy for pharmaceutical companies that presents significant issues and dictates immediate changes. Effective July 20, pharmaceutical companies can no longer run pharmaceutical ads in the so-called “Black Box Ad Format” – a format that had previously been approved by the FDA. Instead, pharmaceutical companies will now have to run
Search Engine Marketing (SEM)
Google Amends Its U.S. Trademark Policy: Creates ‘Special Advertiser’ Status to Allow Use of Another Trademark in Ad Copy
By Andrew R. Boortz on
Using another’s trademark as a keyword for online search marketing purposes is a murky area of law. Is this trademark infringement? Is this a permissible action? Although one may assume that these questions are two sides of the same coin, in reality they are not. The case law on this issue – especially those cases…